These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21887536)

  • 1. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients.
    Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH
    Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders.
    Jaimini A; Tripathi M; D'Souza MM; Panwar P; Sharma R; Mehta S; Pandey S; Saw S; Singh D; Solanki Y; Mishra AK; Mondal A
    Nucl Med Commun; 2013 May; 34(5):426-31. PubMed ID: 23458855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging.
    Lue KH; Lin HH; Kao CH; Hsieh HJ; Liu SH; Chuang KS
    Ann Nucl Med; 2014 Jan; 28(1):33-41. PubMed ID: 24135967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of 6-[
    Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
    J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
    Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
    Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
    J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
    Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
    Dhawan V; Ishikawa T; Patlak C; Chaly T; Robeson W; Belakhlef A; Margouleff C; Mandel F; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):209-16. PubMed ID: 8667046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
    Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
    Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopa and glucose metabolism in PD patients with freezing of gait.
    Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL
    Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.
    Oehme L; Perick M; Beuthien-Baumann B; Wolz M; Storch A; Löhle M; Herting B; Langner J; van den Hoff J; Reichmann H; Kotzerke J
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1550-9. PubMed ID: 21553090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.
    Dhawan V; Ma Y; Pillai V; Spetsieris P; Chaly T; Belakhlef A; Margouleff C; Eidelberg D
    J Nucl Med; 2002 Oct; 43(10):1324-30. PubMed ID: 12368370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A revisit to quantitative PET with
    Akamatsu G; Ohnishi A; Aita K; Nishida H; Ikari Y; Sasaki M; Kohara N; Senda M
    Ann Nucl Med; 2017 Feb; 31(2):163-171. PubMed ID: 27914043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
    Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO
    J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
    Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receiver-operating-characteristic analysis of an automated program for analyzing striatal uptake of 123I-ioflupane SPECT images: calibration using visual reads.
    Kuo PH; Avery R; Krupinski E; Lei H; Bauer A; Sherman S; McMillan N; Seibyl J; Zubal G
    J Nucl Med Technol; 2013 Mar; 41(1):26-31. PubMed ID: 23401604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.